We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-10.83%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.55B
AUM Growth
-$222M
Cap. Flow
-$13.5M
Cap. Flow %
-0.87%
Top 10 Hldgs %
17.52%
Holding
929
New
38
Increased
323
Reduced
374
Closed
111

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.49M
2
KO icon
Coca-Cola
KO
+$4.72M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.71M
4
PX
Praxair Inc
PX
+$2.45M
5
XOM icon
ExxonMobil
XOM
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Financials 11.52%
3 Technology 11.46%
4 Consumer Staples 8.85%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPG
926
DELISTED
Shire pic
SHPG
-3,816
Closed -$692K
SLY
927
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
-3,188
Closed -$240K
CZR
928
DELISTED
Caesars Entertainment Corporation
CZR
-18,560
Closed -$190K
FTF.RT
929
DELISTED
Franklin Limited Duration Income Trust Rights (expiring October 18, 2018)
FTF.RT
-17,265
Closed -$4K

Similar funds

Raymond James Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Trust held 929 positions worth $1.55B, down 12% from $1.78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q4 2018 filing shows 38 new, 323 increased, 374 reduced and 111 closed positions. Its largest new stake was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M. The largest sale was Merck, an estimated $5.49M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • Raymond James Trust's largest Q4 2018 buy was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M.
  • Raymond James Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $3.75M increase.
  • Raymond James Trust's biggest Q4 2018 reduction was Merck, cutting an estimated $5.49M.
  • Raymond James Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.71M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.55B portfolio in Q4 2018.
  • Raymond James Trust opened 38 new positions and closed 111 in Q4 2018.
  • Raymond James Trust's portfolio value fell 12% quarter-over-quarter to $1.55B.

Based on Raymond James Trust's 13F filing for Q4 2018, filed 29 Jan 2019.